PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Upregulation of miR-382 contributes to renal fibrosis secondary to aristolochic acid-induced kidney injury via PTEN signaling pathway.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32796834 ↗2020Reported benefit

Upregulation of miR-382 contributes to renal fibrosis secondary to aristolochic acid-induced kidney injury via PTEN signaling pathway.

MouseChemical/toxinC57BL/6J, including miR-382 knockout miceMalen = n = 6 per group at days 1, 3, 7, 14 and 28Intraperitoneal10 mg/kg anti-miR-382First dose within 30 minutes before aristolochic acid injection

Model: Aristolochic acid I nephropathy, single intraperitoneal dose of 10 or 20 mg/kg

Aristolochic acid caused dose- and time-dependent renal fibrosis through NF-kappaB-driven miR-382 upregulation, and miR-382 knockdown or knockout partially reversed tubulointerstitial fibrosis and inflammation.

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.